Category: Static

Respiratory virus activity continues to climb: 5 notes

Respiratory illness activity remains high nationwide, with emergency department visits and positive test rates rising for COVID-19, seasonal influenza and respiratory syncytial virus, according to a Jan. 3 news release from the CDC. 

$125M Washington hospital to open: 4 updates

Prosser (Wash.) Memorial Health will open a new $125 million hospital on Feb. 1.

Illinois system names new CEO

Jay Carmichael has been named president and CEO of Paris, Ill.-based Horizon Health, effective Jan. 20.

Rhode Island hospital to pay $1.9M in unpaid wages settlement

The U.S. Labor Department has reached a $1.9 million settlement for back wages for workers at Kent Hospital in Warwick, R.I., and its parent organization, Providence, R.I.-based Care New England.

Best hospitals for patient safety, per Women's Choice Award

The Women’s Choice Award has recognized 457 hospitals on its annual list of the Best Hospitals for Patient Safety.

Michigan system CEO shares key leadership insights for hospital acquisitions

Flint, Mich.-based Insight Health System acquired Coldwater (Mich.) Regional Hospital from Toledo, Ohio-based ProMedica on Dec. 1, 2024, after signing a definitive agreement in September.

Pennant Group completes $80M home health acquisition

The Pennant Group has acquired seven Signature Healthcare at Home locations in Oregon.

Trinity hospital fined for unapproved closure of maternity unit

Connecticut’s Office of Health Strategy has fined Stafford-based Johnson Memorial Hospital $153,500 for closing its labor and delivery unit without certificate-of-need approval.

Antidepressant fails in final stage study

Neumora Therapeutics announced that its antidepressant candidate, navacaprant, did not meet the primary endpoint in a Phase 3 study for major depressive disorder. 

Eli Lilly to join lawsuit over GLP-1 shortage: 4 things to know

Eli Lilly is intervening in a lawsuit filed by a trade group representing compounding pharmacies, aiming to block the FDA’s determination that the shortage of its GLP-1 medications, Mounjaro and Zepbound, has ended.